Tracking FSH levels during fertility treatment
Part of Women’s health & pregnancy clinical trials.
This study looks at levels of a hormone called FSH during fertility treatment that stimulates your ovaries. It aims to see if these levels can help guide your treatment, but the study itself does not change the medication you receive.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently getting fertility treatment to stimulate your ovaries (either starting or already in progress).
- You are 44 years old or younger.
- You are not doing this treatment to preserve fertility before cancer treatment.
- You are using one of these fertility medications: Gonal-F, Menopur, Rekovelle, or Puregon.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether tracking a hormone called FSH during ovarian stimulation can help find the best level for egg development. It may help improve your chances in fertility treatment.
This trial compares two doses of follicle-stimulating hormone (FSH) to find out which dose helps women with normal ovarian reserve have better IVF outcomes. It aims to improve the chances of a successful pregnancy.
This trial tests two different starting doses of a fertility drug (follicle-stimulating hormone, or FSH) during a specific IVF preparation method called PPOS. The goal is to see which dose leads to better egg development for women with good fertility prospects.
This study compares two methods of stimulating the ovaries before IVF: one using a standard hormone (hCG) and another using a different protocol. The goal is to see if the new method works as well as the standard one, while possibly being more cost-effective.
This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.
This study looks at how follitropin delta is used in real clinics to help women stimulate eggs for IVF or ICSI. It may help doctors fine-tune dosing by comparing outcomes in everyday practice.
Hear when a new Female Subjects Undergoing Controlled Ovarian Hyperstimulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.